Monitoring microbicide gel use with real-time notification of the container's opening events: Results of the CAPRISA wisebag study

AIDS and Behavior

Volumn 18, Issue 5, 2014, Pages 833-840

  Gengiah, Tanuja N ^a   Upfold, Michele ^a   Naidoo, Anushka ^a   Mansoor, Leila E ^a   Feldblum, Paul J ^b   Abdool Karim, Quarraisha ^a,c   Abdool Karim, Salim S ^a,c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b FHI 360   (United States)

^c Department of Medicine   (United States)

Author keywords

Adherence; Clinical trials; Electronic monitoring; HIV prevention; Microbicides

Indexed keywords

ANTIINFECTIVE AGENT; GEL;

ADULT; COITUS; DEVICES; DRUG DELIVERY SYSTEM; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GEL; HIV INFECTIONS; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MEDICATION COMPLIANCE; MOBILE PHONE; PILOT STUDY; QUESTIONNAIRE; TEXT MESSAGING;

ADMINISTRATION, INTRAVAGINAL; ADULT; ANTI-INFECTIVE AGENTS; CELL PHONES; COITUS; DRUG DELIVERY SYSTEMS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GELS; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; PILOT PROJECTS; QUESTIONNAIRES; TEXT MESSAGING;

EID: 84899626659     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-014-0750-y     Document Type: Article

References (18)

1. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168-74.
2. Lagakos SW, Gable AR. Methodological challenges in biomedical HIV prevention trials. Washington, DC: Institute of medicine; 2008.
3. Schroder KE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med. 2003;26(2):104-23.
4. Tolley EE, Harrison PF, Goetghebeur E, et al. Adherence and its measurement in phase 2/3 microbicide trials. AIDS Behav. 2009;14:1124-36.
5. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79-87.
6. Simoni JM, Kurth AE, Pearson CR, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227-45.
7. Pequegnat W, Fishbein M, Celentano D, et al. NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. Sex Transm Dis. 2000;27(3):127-32.
8. Haberer JE, Kahane J, Kigozi I, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010;14:1340-6.
9. Krummenacher I, Cavassini M, Bugnon O, Schneider MP. An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care. 2011;23:1-12.
10. Lyimo RA, van den Boogaard J, Msoka E, et al. Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the medication event monitoring system. BMC Public Health. 2011;11(1):92.
11. Daniels T, Goodacre L, Sutton C, et al. Accurate assessment of adherence: self and clinician report versus electronic monitoring of nebulizers. Chest. 2011;140:425-32.
12. Russell-Minda E, Jutai J, Speechley M, et al. Health technologies for monitoring and managing diabetes: a systematic review. J Diabetes Sci Technol. 2009;3(6):1460-71.
13. Walji MF, Coker O, Valenza JA, et al. A persuasive toothbrush to enhance oral hygiene adherence. AMIA Annu Symp Proc. 2008:1167.
14. Boyce JM, Cooper T, Dolan MJ. Evaluation of an electronic device for real-time measurement of alcohol-based hand rub use. Infect Control Hosp Epidemiol. 2009;30(11):1090-5.
15. Shet A, Arumugam K, Rodrigues R, et al. Designing a mobile phone-based intervention to promote adherence to antiretroviral therapy in South India. AIDS Behav. 2010;14(3):716-20.
16. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968-77.
17. Pool R, Montgomery CM, Morar NS, et al. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the microbicides development programme. PLoS ONE. 2010;5(7):e11600.
18. van der Straten A, Montgomery E, Pillay D, et al. Feasibility, performance, and acceptability of the Wisebag for potential monitoring of daily gel applicator use in Durban, South Africa. AIDS Behav. 2013;17(2):640-8.